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Background: A challenge in gene therapy is the efficient delivery of DNA/siRNA to the diseased cells. The
physicochemical characteristics of siRNA, such as high molecular weight, negative charges and hydrophilic nature—
prevent passive diffusion across the plasma membrane for most cells. A therapeutically feasible carrier for intra-cellular
delivery of gene materials should accomplish a series of tasks such as: condensing nucleic acid, protecting nucleic
acid from leaking in vivo, facilitating endosome escape and releasing DNA/siRNA to the target site. To meet
these requirements, an efficient gene vector based on polycation synthesis for siRNA delivery both in vitro
and in vivo was developed.
Results: The polymer was synthesized by 1, 4-butanediol bis (chloroformate) and PEI 800 Da to form PEI-Bu
which could condense siRNA at the N/P ratio of 38.35 or above. The size of the nanoparticles was 100–300 nm and zeta
potential was in the range of 10–30 mV at different N/P ratios. The nanoparticles can achieve the ability of cellular
uptake and the silencing efficiency was about 46.63% in SMMC-7721 cell line which was generated to stably express
GL3 luciferase gene. The cytotoxicity of the polyplex nanoparticles was almost negligible on SMMC-7721 cells by MTT
assay, indicating that the reduced luciferase expression was the effect of RNAi, not the influence of cytotoxicity of
polyplexes. The polyplex nanoparticle formulated by PEI-Bu and siRNA at N/P ratio of 115.05 was injected into the
SMMC-7721 tumor bearing mice locally and the expression of luciferase can reduce to 63.17% compared with
control group.
Conclusions: Results in this study suggested that PEI-Bu polycation might provide a promising solution for siRNA
delivery and had the potential in anti-tumor gene therapy.
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Small interfering RNA (siRNA) was synthesized to provide
a powerful tool to identify the mechanism for given dis-
ease and may provide a promising therapeutic method for
gene related disease [1-3]. However, siRNA was unstable
and easily to be degraded and eliminated during systemic
circulation. Meanwhile, the high molecular weight and
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unless otherwise stated.There are still many biological barriers which should over-
come to achieve the safe and efficient delivery of siRNA
into the cytoplasm of diseased cells [4-6]. A feasible nu-
cleic acid vector is expected to accomplish inter- and
intra- cellular trafficking for siRNA delivery. Recombinant
retrovirus, adenovirus, and adeno-associated virus - based
vectors may have high transfection efficiency; however,
the clinical use of viral vector was retarded by its im-
munogenicity, toxicity, lack of tissue specificity and poten-
tial risk of inducing tumorigenic mutations. Comparing
with viral vectors, nonviral vectors possess a series of ad-
vantages to condense siRNA and promote the efficiency
of transfection [7-9].
To deliver nucleic acid to the target site of diseased
cells, synthetic gene vectors should accomplish a seriesThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Agarose gel electrophoresis result of the PEI-Bu
polyplex. Polyplex formed from polymer to siRNA at N/P ratio of
3.84, 7.67, 23.01, 38.35, 76.7, 115.05, 153.4.
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particulates to avoid premature degradation, 2) absorb-
ing onto the diseased cells to enhance cellular uptake,
3) endosome escape after endocytosis, 4) releasing siRNA
into cytoplasm, 5) metabolizing into toxicity-free mole-
cules. Non-viral vectors based on lipids have proven to be
effective in gene delivery both in vitro and in vivo [10], but
the low efficiency in siRNA condensation results in large
particle sizes which may raise the concern of vector stabil-
ity in vivo [11-14]. Polymer based gene carriers can con-
dense siRNA to nano-sized particles and may facilitate
endocytosis and endosome escape due to the “proton
sponge” mechanism. A rationally designed polycation may
accomplish task 1), 3), 4), and 5) mentioned above for
siRNA delivery. There have been numerous cationic
polymers reported to date for siRNA delivery, such as
polyethyleneimine (PEI), poly-L-Lysine (PLL), poly (amide
amine) (PAMAM). Despite considerable progress has
been made in polycatonic delivery, safety improvement
and effectiveness for clinical trials still leaves a big gap to
be met in the future [15-18]. An important prerequisite
for the therapeutic applications of siRNA is the successful
delivery to the diseased cells and the subsequent release in
the cytoplasm [19,20].
PEI 25 K exhibits excellent ability to condense nucleic
acid to form nano-sized particles due to its high dens-
ity of cationic charges and high transfection efficiency
in vitro. However, the lack of the degradable linkages
may cause undesirable toxicity which would probably
to hinder its therapeutic applications. Compared with
PEI 25 K, small molecular weight PEI has relative low
cytotoxicity, however, the transfection efficiency was also
compromised [21-23]. Linkers that are able to form
degradable linkages, such as dithiobis succinimaidyl pro-
pionate and dimethyl-3, 3′-dithiobispropionimidate, are
used to generate polycation to condense gene materials
and achieve the ability of high transfection efficiency. PEI-
Bu which uses 1, 4-butanediol bis (chloroformate) as the
linker to form carbamate linkages between PEI 800 kDa
molecules, exhibits higher transfection efficiency with
relative low cytoxicity in various cell lines.
In previous study, we have synthesized a biodegradable
small-molecular-weight PEI (Mw: 800 Da) derivative
with a carbamate linkage named PEI-Bu (Number-
average Molecular Weight, Mn: 3278, Weight-average
Molecular Weight, Mw: 4289). The transfection and
characterization details of the polyplex formed by PEI-Bu
and plasmids on rat primary synoviocytes were studied
as well [24]. In this work, PEI-Bu was used to com-
plex with siRNA to study the physical characteristic
polyplex and the transfection effect in SMMC-7721. The
Luciferase GL3 siRNA formulated in polyplexes was locally
injected to measure gene silencing efficiency in tumor-
bearing mice.Results and discussion
Characterization of PEI-Bu/siRNA polyplexes
The siRNA condensing efficiency of PEI-Bu was deter-
mined by agarose gel electrophororesis. As shown in
Figure 1, siRNA can be retarded at the well when N/P
ratio of PEI-Bu to siRNA reached above 38.35. It can be
concluded that this polymer could achieve the ability of
condensing siRNA completely. The sizes of the formed
nanoparticles were measured by dynamic light scattering
(DLS). As shown in Figure 2, the size of the polyplex
was in the range of 100 to 300 nm. When the N/P ratio
reached 115.05, the average size was 157.34 nm and well
distributed with the narrow polydisersity index (PDI)
0.173. As shown in Figure 2, zeta potential was in the
range of 10–30 mV during the experiment. From the evi-
dences of electrophoresisis, Transmission electron micros-
copy (TEM) image, size and zeta potential measurement,
all the results indicated the capability of PEI-Bu to pack
siRNA into nano-sized polyplexes. Particle size of PEI-Bu
polyplex in saline and BSA solution was determined. As
shown in Figure 2c, particle size of the formed polyplex in
saline was slightly changed from 180 nm to 226 nm after
12 hours incubation at 37°C which indicated that the poly-
plex was stable in vitro. While in the BSA solution, the
size of PEI-Bu polyplex was smaller than 300 nm in
6 hours and increased to about 600 nm after 48 hours at
37°C. It can be concluded that the PEI-Bu siRNA polyplex
was relative stable in saline and BSA solution.
Cellular uptake experiment
The cellular uptake of the PEI-Bu/siRNA polyplex nano-
particles was performed on SMMC-7721 cell. siRNA
was labeled by fluorescence dye TARMA (red) and con-
densed by the PEI-Bu cationic polymer. Endosome was
labeled by Lyso-tracker green DND-26 (green). After in-
cubation, the culture medium was discarded and washed
Figure 2 Characterization and stability of PEI-Bu polyplex. (a) Size distribution and zeta potential of the PEI-Bu polyplex nanoparticles at N/P
ratio of 3.84, 7.67, 23.01, 38.35, 76.7, 115.05, 153.4. (Data represent as mean ± SD). (b) TEM image of the PEI-Bu polyplex nanoparticles at N/P ratio
of 115.05. (c) Size of PEI-Bu polyplex in the presence of saline and FBS during 48 hours.
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extracellular fluorescence was quenched by typan blue.
Then add PBS to each well and observe under the fluor-
escence microscope. As shown in Figure 3, the cells in-
cubated with naked siRNA group and saline group
show nearly no fluorescent signals. For the polyplex
group treated in the same method, red fluorescent
signals were visualized around endosome which was
labeled by fluorescence dye lysotracker green in theFigure 3 Cellular uptakes of the PEI-Bu nanoparticles in
SMMC-7721 cell. The lysosome was labeled by lysotracker
green. The polyplex was labeled by TAMRA-siRNA.cytoplasm compartment. It can be concluded that with
the delivery vehicle of PEI-Bu siRNA uptake by SMMC-
7721 cell was significantly improved.
Silencing efficiency of the PEI-Bu/siRNA polyplexes
The silencing efficiency of the PEI-Bu/siRNA polyplex
was performed on SMMC-7721 cell (stably expressing
luciferase gene). Polyplexes formed at N/P ratio of 3.84,
7.67, 23.01, 38.35, 76.7, 115.05 and 153.4 were prepared
as described and added to each well. The cells were in-
cubated with saline (control), naked siRNA (no sense or
antisense) and polyplex formulated in different N/P ra-
tio. After 48 hours, luciferase expressing was determined
by using saline group as 100%. As shown in Figure 4, the
best silencing efficiency of luciferase expression was ac-
quired by the complexes at polymer to gene ratio (N/P)
of ratio of 115.05. The silencing efficiency of the poly-
plex could achieve 46.63%. Luciferase expression was
expressed as substrate luminescence per mg protein nor-
malized by the total protein content of the cells that
have been transfected in each sample.
Cytotoxicity of the PEI-Bu/siRNA nanoparticles
The toxicity of the PEI-Bu cationic polymer had been in-
vestigated in a previous study [24]. However, cytotoxicity
of the polyplex containing siRNA should be taken into
Figure 4 Silencing efficiency of PEI-Bu/siRNA polyplexes in
SMMC-7721 cell. SMMC-7721 cell was stably expressing Luciferase
gene, the polyplex was formed at N/P ratio of 3.84, 7.67, 23.01, 38.35,
76.7, 115.05, 153.4, saline was used as control. The result was
expressed as mean ± SD.
Figure 5 Cytotoxicity of PEI-Bu siRNA nanoparticles in different cell li
ratio of 3.84, 7.67, 23.01, 38.35, 76.7, 115.05, 153.4 by using normal group as
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of SMMC-7721 treated with PEI-Bu/siRNA polyplex was
measured by MTT assay. As shown in Figure 5, the nano-
particles were with a negligible cytotoxicity during the
test. Compared with non-toxic control group, cell viability
was almost above 80%. This result suggested that the si-
lencing effect of the luciferase was not caused by the tox-
icity of the polyplex nanoparticles. The advantage of the
cytotoxicity-free PEI-Bu/siRNA nano-carriers for gene de-
livery was making it possible to be used therapeutically.
Silencing efficiency of the PEI-Bu/siRNA polyplex in
SMMC-7721 tumor bearing mice
SMMC-7721 cells (stably expressing luciferase gene) were
injected subcutaneously into the nude mice, where the
solid tumor will be formed. Naked siRNA, polyplexes at
the N/P 115.05 were locally injected into tumor respect-
ively by using saline as the control. The mice were sacri-
ficed after 48 hours and tumor tissue was separated and
lysated. Luminescence was measured and the silencing ef-
ficiency was calculated relative to saline group as 100%.nes. (a) Hela (b) HepG2 (c) CT26 (d) HL7702 (e) SMMC-7721 at N/P
100%. (n = 6, data represent mean ± SD).
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no silencing effect while the polyplex group at the poly-
mer to siRNA N/P of 115.05 gave the silencing efficiency
which was about 63.17% (as shown in Figure 6). This re-
sult further proved that the polyplex formed from PEI-Bu
and siRNA might achieve the ability of intra-cellular deliv-
ery of siRNA to SMMC-7721 cancerous cell as desired. As
shown in Figure 7, comparing with saline control group,
the polyplex group was with a negligible toxicity after tail
vein injection which indicated that this system could
achieve the ability of delivering therapeutic agent with low
toxicity as desired.
Conclusions
PEI 25 K was used as a positive transfection agent in vivo,
but cytotoxicity has largely prohibited its clinical use
in vivo. Combined the low toxicity and high transfection
efficiency of PEI derivatives, biscarbamate cross-linked
low molecular weight PEI polycation was promising
to be used for intracellular delivery of siRNA in vitro
and in vivo. The PEI-Bu polycation could condense
siRNA into nano-sized particles by electrostatic inter-
action. The sizes of the polyplex were in the range of
100–300 nm and zeta potential was about 10–30 mV at
different N/P ratio. Saline and BSA solution were used to
mimic the physiological environment to measure the sta-
bility of the PEI-Bu polyplex. Size of the PEI-Bu siRNA
nanoparticle was more stable in saline than in BSA solu-
tion. One explanation for increased size of PEI-Bu nano-
particle in BSA was probably caused by the aggregation of
the BSA protein. All of the characterizations mentioned
above made PEI-Bu polycation a potential and promising
agent to be used in gene transfection. Polyplex formed
of PEI-Bu cationic polymer and siRNA could achieve
the ability of cellular uptake in SMMC-7721 cell byFigure 6 Silencing efficiency of the PEI-Bu/siRNA polyplex. The
N/P ratio of PEI-Bu to siRNA was 115.05. Saline was used as control
in SMMC-7721 (stably expressing luciferase gene) tumor bearing
mice. (n = 6, data represent as mean ± SD).fluorescence image and the silencing efficiency in
SMMC-7721 cell (stably expressing luciferase gene)
was about 46.63%. The cytotoxicity of the polyplex at
the same ratio was low and the result suggested that the
silencing efficiency was not caused by toxicity of the
vector. Silencing efficiency of the nanoparticles in
tumor tissue was 63.17%. All the results suggested
that PEI-Bu may provide a promising method for




Polyethyleneimine 25 KDa (PEI 25 KDa), 1, 4-Butanediol bis
(chloroformate), Dimethyl Sulfoxide BioReagent (DMSO,
for molecular biology) and ethidium bromide (EB) were pur-
chased from Sigma-Aldich. 5-diphenyltetrazoliumbromide
(MTT) was obtained from Solarbio Science & Technology
Co., Ltd (Beijing, China). 0.4% Trypan blue solution
was purchased from Amresco (Solon, OH). Micro BCA™
Protein Assay Kit was purchased from Thermo Scientific
(Rockford, IL). Luciferase Assay Kit was purchased from
Promega (Madison, WI). Water was purified using a
Milli-Q instrument (Millipore). Other chemicals used
were analytical grade.
Dulbecco’s Modified Eagle’s Medium (DMEM), Fetal
Bovine Serum Gold (FBS) and Trypsin-EDTA solution
were purchased from PAA. Lyso-Tracker™ Green DND-26
was purchased from Invitrogen. pGL3 luciferase gene
siRNA and Allstars Negative Control siRNA (Cat. No.
1027280) were obtained from Qiagen. TAMRA labeled
siRNA was purchased from GenePharm. All the materials
used for siRNA experiments were processed with DEPC
to keep RNase free.
Cell culture
The SMMC-7721 cell lines (Human hepato-cellular car-
cinoma cell line) were purchased from the Cell Bank of
Chinese Academy of Sciences (Shanghai, China) and cul-
tured in DMEM medium with 10% FBS. Cells were
maintained at 5% CO2 incubator at 37°C.
Animals
BALB/c nude mice (5 weeks) were maintained under
SPF degree environment for a week before the tumor in-
oculation. The animal experiments were carried out
in accordance with the guidelines of “Regulations for the
Administration of Affairs Concerning Laboratory Animals”
and “The National Regulation of China for Care and Use
of Laboratory Animals”.
Synthesis of the PEI-Bu polymer
Synthesis of the PEI-Bu cationic polymer was proceeded
as described in a previous published paper [24]. Briefly,
Figure 7 Toxicity of the PEI-Bu polyplex. The toxicity of main organ was measured by frozen section after systematical injection of saline,
naked siRNA and polyplex formed by PEI-Bu and siRNA at N/P ratio of 115. The nucleus was stained in an aqueous solution of hematoxylin.
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chloroform (40 mL) was added dropwise to a PEI 800 Da
(1.8 g, 3 mmol) chloroform solution (6 mL) at 0°C with
stirring in anhydrous environment. The reaction was vig-
orously stirred for 24 hours at room temperature. The
solvent was then removed under reduced pressure to ob-
tain the crude product. After dialysis by 3500 Da dialysis
bag for 24 h to remove small fragments, the dialysate was
freeze-dried to obtain the final product. The PEI-Bu poly-
mer was kept at −80°C in a dry environment before use.
Preparation and characterization of PEI-Bu/siRNA
polyplexes
PEI-Bu/siRNA polyplexes were prepared by adding the
PEI-Bu solution into siRNA solution at polymer to
siRNA N/P ratio of 3.84, 7.67, 23.01, 38.35, 76.7, 115.05
and 153.4 and incubated at room temperature for
30 min. The formed siRNA nanoparticles were loaded
on a 3.0% agarose gel containing 0.5 μg/mL ethidiumbromide and subjected to electrophoresis at 110 V for
40 min. The retardation of siRNA was visualized by
UV illuminator to identify condensing efficiency. The
particle size and distribution of the polyplex at differ-
ent N/P ratio in water and saline were measured by
using Brookhaven Particle Size Analyzer (90 Plus), the
Zeta potential of the nanoparticles was determined by
using the same instrument as well. The values of the par-
ticle sizes and Zeta potentials were calculated by four indi-
vidual experiments. A transmission electron microscopic
(TEM, JEM 2010 system JEOL, Japan) was used to ob-
serve the image of the PEI-Bu siRNA polyplex.
Saline and BSA solution were used to mimic the physio-
logical conditions to indicate the stability of the particles.
The PEI-Bu siRNA polyplex was prepared as described
and incubated in saline and BSA solution at 37°C separ-
ately for 48 hours. Particle size was determined at 0, 1, 3,
6, 12, 24, 36, 48 hours to study the stability of the formed
polyplexes.
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SMMC-7721 cells were seeded in 12-well plate at the
density of 8000 cells per well in 1 mL DMEM complete
medium and incubated overnight. The fluorescence dye
TAMRA (red) labeled siRNA was complexed with PEI-
Bu as described before. The medium was discarded,
washed with PBS and replaced with 500 μL fresh FBS
free DMEM. Polyplex nanoparticles was added to the
cell and incubated for 4 h at 5% CO2 incubator at 37°C.
The endosome was labeled with lyso-tracker green. After
4 h, the medium was washed and replaced with PBS. The
trypan blue was used to quenched the extracellular fluor-
escence at 500 μL per well for 2 min. After the medium
was removed, cells were washed with PBS for three times
and observed under a fluorescence microscope (Nikon
Eclipse TS-100 Inverted Fluorescent Microscope, Japan)
to determine the internalization efficiency of the poly-
plexes by SMMC-7721 cell.
Silencing efficiency of the PEI-Bu/siRNA polyplexes
Silencing efficiency of polyplexes at different N/P ratios
was determined by transfection of anti-pGL3 luciferase
siRNA in SMMC-7721 cell which was stably expressing
luciferase gene. SMMC-7721 cells were seeded in 48-
well plate at a density of 6 × 104 cells per well in 500 μL
DMEM complete media containing 10% FBS overnight at
37°C in a 5% CO2 incubator. Polyplexes were prepared as
mentioned above and added into each well accordingly.
After incubated at 37°C in serum-free medium for 4 hours,
the medium was discarded, washed with PBS and replaced
by fresh medium containing 10% FBS and further incu-
bated for 48 hours. To determine the silencing efficiency
of luciferase gene, the transfected cells were washed with
PBS solution and lysed with 1× cell culture lysis buffer
(Promega) followed by centrifugation at 12000 rpm for
3 min (Eppendorf 5810 R Centrifuge, Germany). After
mixing 20 μL supernatant with 20 μL substrate (Luciferase
Assay System, Promega), luminescence was measured im-
mediately by a single tube luminometer (Sirius – Single
Tube Luminometer from Berthold Detection Systems
GmbH). The concentration of the protein was determined
by Micro BCA™ Protein Assay Kit (Thermo Scientific
Pierce). Luciferase activity of each sample was normalized
on protein concentration and expressed as the percent
luminescence intensity by using the normal group as
a control.
Cytotoxicity of the PEI-Bu/siRNA nanoparticles
Cytotoxicity of the PEI-Bu/siRNA polyplexes was mea-
sured by MTT assay in SMMC-7721 cell line. SMMC-
7721 cells were seeded in 96-well plate at the density of
8000 cells per well overnight. The culture medium was
discarded, washed with PBS and replaced with serum
and phenol free DMEM. Then the polyplexes at differentN/P ratio were added into each well and the concentra-
tion of the nanoparticles was the same with transfection.
After 4 hours, the medium was removed and the cell
was washed with PBS. The medium was replaced by
100 μL fresh medium (without serum and phenol) and
25 μL MTT solution (5 mg/mL in PBS) was added into
the cells and incubated for another 6 hours. Viable cells
were determined by measuring the absorbance of the
samples at 570 nm with a Spectra Max M3 Multi-Mode
Microplate Reader with 630 nm as the reference. Cell vi-
abilities were calculated by comparison with the normal
cells as 100%. The data were expressed as mean values
(±standard deviations) of six experiments.
Silencing efficiency of PEI-Bu/siRNA polyplex in
SMMC-7721 tumor bearing mice
SMMC-7721 cells stably expressing luciferase gene were
injected subcutaneously into the mice. When the volume
of tumor reached approximately 200 mm3, the naked
siRNA, polyplexes at the N/P ratio of 115.05 were locally
injected into the tumor at a dose of 0.5 mg/kg (in
200 μL saline) by using saline as control. The mice were
sacrificed after 48 hours and the tumor tissue was iso-
lated, homogenized in liquid nitrogen and lysated in 5×
culture lysis buffer and centrifugated at 12000 rpm for
3 min. Luminescence was measured by a single tube
luminometer and normalized on protein concentration.
The silencing efficiency was calculated relative to saline
group as 100%.
Toxicity of PEI-Bu polyplex in main organ was mea-
sured after systematical injection of saline, naked siRNA,
polyplex formed by PEI-Bu and siRNA at N/P ratio of 115
respectively. The main organ heart, liver, spleen, lung, kid-
ney was isolated and subjected to frozen section to meas-
ure the toxicity of the different formulation (the nucleus
was stained in an aqueous solution of hematoxylin).
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